RB.L - Reckitt Benckiser Group plc

LSE - LSE Delayed price. Currency in GBp
6,766.00
-34.00 (-0.50%)
As of 3:02PM GMT. Market open.
Stock chart is not supported by your current browser
Previous close6,800.00
Open6,808.00
Bid6,766.00 x 20000
Ask6,767.00 x 3500
Day's range6,718.00 - 6,818.00
52-week range6,299.00 - 8,110.43
Volume580,391
Avg. volume1,688,637
Market cap47.61B
Beta0.76
PE ratio (TTM)26.58
EPS (TTM)254.60
Earnings date19 Feb 2018
Forward dividend & yield1.71 (1.83%)
Ex-dividend date2017-08-17
1y target est7,529.14
  • Reuters - UK Focus2 days ago

    Health-conscious Nestle sells U.S. candy to Ferrero for $2.8 bln

    LONDON/MILAN, Jan 16 (Reuters) - Swiss food group Nestle has agreed to sell its U.S. confectionery business to Italy's Ferrero for $2.8 billion, it said on Tuesday, marking CEO Mark Schneider's first big sale and a small step on its path towards healthier products. Nestle, the world's biggest packaged-food company, has cited the unit's weak position in the United States, where it trails Hershey, Mars Inc and Lindt, as the rationale for a sale. For family-owned Ferrero, the cash deal offers a chance for the Italian company to build scale quickly in that key market, where it has done two other deals in the past year.

  • 2 great stocks I’d buy and hold forever
    Fool.co.uk4 days ago

    2 great stocks I’d buy and hold forever

    Bilaal Mohamed picks out two stress-free blue-chip defensives to buy and hold for the longer term.

  • Reuters8 days ago

    Nestle frontrunner for Merck KGaA's consumer health business - Bloomberg

    ZURICH (Reuters) - Nestle (NESN.S) is the frontrunner to buy Merck KGaA's (MRCG.DE) consumer health unit that could fetch as much as $5 billion, financial news service Bloomberg said on Wednesday, quoting ...

  • Reuters - UK Focus8 days ago

    Nestle frontrunner for Merck KGaA's consumer health business - Bloomberg

    Nestle is the frontrunner to buy Merck KGaA's consumer health unit that could fetch as much as $5 billion, financial news service Bloomberg said on Wednesday, quoting unidentified sources familiar with ...

  • Reuters14 days ago

    Unilever to close UK Colman's mustard factory

    Unilever (ULVR.L)(UNc.AS) plans to close its Colman's mustard factory in the English city of Norwich next year, after more than 160 years, affecting 113 jobs. Production of the condiment will likely start to be transferred this year to other British sites including Burton upon Trent, where Marmite and Bovril are made, with some packing moving to Germany, the company said on Thursday. The decision follows a review launched in October when UK soft drink maker Britvic (BVIC.L) announced the closure of its Norwich factory, on a site co-owned with Unilever.

  • Reuters - UK Focus14 days ago

    Unilever to close UK Colman's mustard factory

    Unilever (NYSE: UL - news) plans to close its Colman's mustard factory in the English city of Norwich next year, after more than 160 years, affecting 113 jobs. Production of the condiment will likely start to be transferred this year to other British sites including Burton upon Trent (BSE: 500251.BO - news) , where Marmite and Bovril are made, with some packing moving to Germany, the company said on Thursday. The decision follows a review launched in October when UK soft drink maker Britvic announced the closure of its Norwich factory, on a site co-owned with Unilever.

  • Reuters14 days ago

    Boutique M&A advisory firm Robey Warshaw sees profits surge after major deals

    Robey Warshaw, the small boutique advisory firm that has worked on some of Britain's biggest deals, saw its annual profits soar 73 percent to more than 60 million pounds, according to a company filing. The firm, founded by veteran investment bankers Sir Simon Robey, Simon Warshaw and Philip Apostolides in 2013, has quickly established itself as one of the UK's leading M&A advisory businesses with roles in blockbuster deals, including Royal Dutch Shell's (RDSa.L) $53 billion acquisition of BG Group, announced in 2015, and Reckitt Benckiser's (RB.L) $16.6 billion purchase of U.S. baby formula maker Mead Johnson Nutrition last year. It came as turnover at Robey Warshaw leapt to 72.7 million pounds from 43.3 million pounds as the firm, which is based in London's upmarket Mayfair district, netted fees from deals that closed in the period.

  • A $17 Billion Dilemma for Reckitt's CEO
    Bloomberg22 days ago

    A $17 Billion Dilemma for Reckitt's CEO

    Rakesh Kapoor must decide whether to go for Pfizer's consumer arm.

  • Reuterslast month

    Chinese tourists raid Danish supermarkets for infant milk powder

    Following a string of food safety scandals, Chinese tourists visiting Copenhagen have this year stocked up on Danish-made organic infant milk formula, prompting some supermarkets to limit the number of cans each customer can buy. Arla Foods, one of Europe's biggest dairy companies, says Chinese demand for premium products and high food safety standards in Denmark have helped it almost double its sales to China this year. Food safety has been an important issue in China since a 2008 scandal killed six infants who had been fed milk powder that had been adulterated with the toxic melamine, normally used to make plastics.

  • Reuters - UK Focuslast month

    Chinese tourists raid Danish supermarkets for infant milk powder

    COPENHAGEN, Dec (Shanghai: 600875.SS - news) 15 (Reuters) - Following a string of food safety scandals, Chinese tourists visiting Copenhagen have this year stocked up on Danish-made organic infant milk formula, prompting some supermarkets to limit the number of cans each customer can buy. Arla Foods, one of Europe's biggest dairy companies, says Chinese demand for premium products and high food safety standards in Denmark have helped it almost double its sales to China this year. Food safety has been an important issue in China since a 2008 scandal killed six infants who had been fed milk powder that had been adulterated with the toxic melamine, normally used to make plastics.

  • Is SDL plc a turnaround stock worth buying before Christmas?
    Fool.co.uklast month

    Is SDL plc a turnaround stock worth buying before Christmas?

    Could SDL plc (LON: SDL) deliver improved share price performance?

  • 2 FTSE 100 growth shares that could make you a million
    Fool.co.uklast month

    2 FTSE 100 growth shares that could make you a million

    Royston Wild looks at two FTSE 100 (INDEXFTSE: UKX) shares that could make you a fortune.

  • Reuters - UK Focus2 months ago

    FTSE 100 holds breath before budget, Thomas Cook dives

    Britain's top share index edged higher on Wednesday as cautious investors awaited finance minister Philip Hammond's budget announcement which could shake up housebuilders, banks and insurance stocks. The ...

  • Reuters2 months ago

    Nestle shakes up infant nutrition to tackle local rivals

    LONDON/ZURICH (Reuters) - Nestle (NESN.S), the world's largest packaged food firm, is reorganising its infant nutrition unit to compete with regional rivals, the latest in a string of shake-ups for global packaged goods companies struggling to reignite sales. The change comes five months after Nestle's new CEO listed its highly profitable infant formula as a priority focus. Infant nutrition is a key battleground for Nestle and rivals such as Danone (DANO.PA), which also ranks its baby unit as its most profitable, and Reckitt Benckiser (RB.L), which recently bought Mead Johnson, the maker of infant formula Enfamil.

  • Reuters - UK Focus2 months ago

    Nestle shakes up infant nutrition to tackle local rivals

    LONDON/ZURICH, Nov 15 (Reuters) - Nestle, the world's largest packaged food firm, is reorganising its infant nutrition unit to compete with regional rivals, the latest in a string of shake-ups for global packaged goods companies struggling to reignite sales. The Swiss maker of Gerber baby food and Illuma formula said on Wednesday it would appoint regional managers for the $10 billion business to address local trends faster. The change comes five months after Nestle's new CEO listed its highly profitable infant formula as a priority focus.

  • Exclusive: Pfizer to launch consumer health sale in November - sources
    Reuters3 months ago

    Exclusive: Pfizer to launch consumer health sale in November - sources

    Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters. Several global companies, including GlaxoSmithKline and Reckitt Benckiser, have expressed interest in bidding for the unit, which had sales of about $3.4 billion in 2016. The prospective sale, which is being led by Centerview Partners, Guggenheim Securities and Morgan Stanley, was first mooted on Oct. 10, when Pfizer said it was considering strategic options for the unit.

  • Reuters3 months ago

    Exclusive: Pfizer to launch consumer health sale in November -sources

    Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters. Several global companies, including GlaxoSmithKline and Reckitt Benckiser, have expressed interest in bidding for the unit, which had sales of about $3.4 billion in 2016. The prospective sale, which is being led by Centerview Partners, Guggenheim Securities and Morgan Stanley, was first mooted on Oct. 10, when Pfizer said it was considering strategic options for the unit.

  • Reuters3 months ago

    FTSE rises to record close, blue-chips shrug off Reckitt blip

    British mid-caps jumped to a record closing level on Wednesday as investors grew more comfortable with the smaller, more domestically-focused stocks, while the FTSE 100 held its ground as third quarter earnings trickled in. The FTSE 250 (.FTMC) was up 0.6 percent on the day, closing at a record 20,263.1 points. Mid-caps have strongly outperformed the bigger index this year, up around 12 percent against the FTSE 100's 6 percent rise.

  • Reckitt to reshape as sales growth evaporates
    Reuters3 months ago

    Reckitt to reshape as sales growth evaporates

    Britain's Reckitt Benckiser will split its business into two divisions -- consumer healthcare and home and hygiene products -- to try to revive sales that are set to stall this year. It hopes to improve performance in its newly expanded health business, while bringing greater focus and accountability to its slower-growth home and hygiene business. Reckitt, whose products range from Durex condoms to Lysol disinfectant, has blamed fallout from a cyber attack, a failed product launch and a safety scandal in South Korea for its lacklustre sales.

  • Reuters - UK Focus3 months ago

    Reckitt to reshape as sales growth evaporates

    LONDON, Oct (Shenzhen: 000069.SZ - news) 18 (Reuters) - Britain's Reckitt Benckiser (Xetra: A0M1W6 - news) will split its business into two divisions -- consumer healthcare and home and hygiene products -- to try to revive sales that are set to stall this year. It hopes to improve performance in its newly expanded health business, while bringing greater focus and accountability to its slower-growth home and hygiene business. Reckitt, whose products range from Durex condoms to Lysol disinfectant, has blamed fallout from a cyber attack, a failed product launch and a safety scandal in South Korea for its lacklustre sales.

  • Pfizer's Advil May Be Just the Thing for Sickly Reckitt
    Bloomberg3 months ago

    Pfizer's Advil May Be Just the Thing for Sickly Reckitt

    The problem is getting shareholders to back a cash call to pay for it.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes